Stay updated on Inhibitors for COVID-19 Clinical Trial

Sign up to get notified when there's something new on the Inhibitors for COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inhibitors for COVID-19 Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A new MATIS-related publication citation (Hazell et al., BMJ Open 2026) was added to the Publications section, and the page shows Revision: v3.4.2; a generic funding-status notice was removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:26:44.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with operating-status guidance and updated the site revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T04:10:59.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    UI and metadata enhancements were implemented: a glossary toggle is shown, and the page now displays Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and the Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T01:14:37.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Administrative update: revision v3.3.4 was added and v3.3.3 was removed, with no impact on study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:18:37.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T17:20:21.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Added explicit study-site details (five locations: Leeds; London—two sites; Reading; Sheffield) with the associated NHS Trusts. Clarified the primary outcome definitions for MATIS and linked related study documents (Protocol, SAP) and data-sharing information.
    Difference
    7%
    Check dated 2025-11-24T21:54:10.000Z thumbnail image

Stay in the know with updates to Inhibitors for COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inhibitors for COVID-19 Clinical Trial page.